Literature DB >> 9112582

Sleep disorder related to Parkinson's disease.

M Partinen1.   

Abstract

Sleep disorders occur in 74-98% of patients with idiopathic Parkinson's disease (PD), adversely affecting their quality of life. Sleep disruption takes the form of sleep fragmentation with frequent and prolonged awakenings and daytime sleepiness. Nocturia, difficulty in turning over in bed, painful leg cramps, vivid dreams/nightmares, back pain, limb/facial dystonia and leg jerks are the main causes of nocturnal awakening in PD patients. Sleep disturbance gradually worsens with disease progression, suggesting that it is related to the severity of the disease. Sleep disturbances may be generally considered as part of the normal aging process, being more common in the elderly. However, no significant associations between sleep disturbances and either age or disease duration was found in a survey of 100 PD patients. Disturbed sleep maintenance in PD patients was more severe than in age-matched controls, and nocturnal awakening was frequently caused by nocturia, pain, stiffness and difficulty in turning over in bed. Sleep disturbance is also a complication of chronic levodopa therapy. Recent data suggest that controlled-release levodopa is less likely to cause nocturnal symptoms than standard levodopa, particularly in mild-to-moderate disease. Depression, which is common in PD patients, contributes to sleep disturbance but has a lesser influence than the disease process itself. Hypnotic and sedative agents, as well as anti-depressants if required, are useful in ameliorating sleep disturbances in PD patients; intranasal desmopressin appears to be effective in reducing nocturia.

Entities:  

Mesh:

Year:  1997        PMID: 9112582     DOI: 10.1007/bf03160564

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  23 in total

1.  Five years' treatment of Parkinson's disease with levodopa. Therapeutic results and survival of 100 patients.

Authors:  R D Sweet; F H McDowell
Journal:  Ann Intern Med       Date:  1975-10       Impact factor: 25.391

2.  Autonomic dysfunction in men with Parkinson's disease.

Authors:  C Singer; W J Weiner; J R Sanchez-Ramos
Journal:  Eur Neurol       Date:  1992       Impact factor: 1.710

Review 3.  Neuroanatomic and neurologic correlates of sleep disturbances.

Authors:  A Culebras
Journal:  Neurology       Date:  1992-07       Impact factor: 9.910

4.  A sustained-release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early-morning disabilities in Parkinson's disease.

Authors:  A J Lees
Journal:  Eur Neurol       Date:  1987       Impact factor: 1.710

5.  Narcolepsy and idiopthic hypersomnia: biogenic amines and related compounds in CSF.

Authors:  J Montplaisir; J de Champlain; S N Young; K Missala; T L Sourkes; J Walsh; G Rémillard
Journal:  Neurology       Date:  1982-11       Impact factor: 9.910

6.  Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep.

Authors:  J J Askenasy; M D Yahr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-09       Impact factor: 10.154

7.  Dopaminergic transmission and the sleep-wakefulness continuum in man.

Authors:  A N Nicholson; P A Pascoe
Journal:  Neuropharmacology       Date:  1990-04       Impact factor: 5.250

8.  Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring.

Authors:  B van Hilten; J I Hoff; H A Middelkoop; E A van der Velde; G A Kerkhof; A Wauquier; H A Kamphuisen; R A Roos
Journal:  Arch Neurol       Date:  1994-09

9.  REM sleep behavioral disorders.

Authors:  E Sforza; M Zucconi; R Petronelli; E Lugaresi; F Cirignotta
Journal:  Eur Neurol       Date:  1988       Impact factor: 1.710

10.  Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis.

Authors:  P A Nausieda; W J Weiner; L R Kaplan; S Weber; H L Klawans
Journal:  Clin Neuropharmacol       Date:  1982       Impact factor: 1.592

View more
  12 in total

1.  The diagnostic dilemma of Parkinson's disease as a cause of calf 'claudication'.

Authors:  Samuel O Ogunbiyi; Mari Coxon; Gareth Morris-Stiff; Michael H Lewis
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

2.  Misperceptions exist about sleep attacks when driving.

Authors:  Jim Horne
Journal:  BMJ       Date:  2002-09-21

Review 3.  Use of sleep-promoting medications in nursing home residents : risks versus benefits.

Authors:  David K Conn; Robert Madan
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

Review 4.  Sleep disorders in the elderly.

Authors:  R Asplund
Journal:  Drugs Aging       Date:  1999-02       Impact factor: 3.923

5.  Enabling breakthroughs in Parkinson's disease with wearable technologies and big data analytics.

Authors:  Shahar Cohen; Lauren R Bataille; Adria K Martig
Journal:  Mhealth       Date:  2016-05-12

Review 6.  Sleep disturbances in patients with Alzheimer's disease: epidemiology, pathophysiology and treatment.

Authors:  M V Vitiello; S Borson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

7.  Alterations of nocturnal activity in rats following subchronic oral administration of the neurotoxin 1-trichloromethyl-1,2,3,4-tetrahydro-beta-carboline.

Authors:  Thomas A Sontag; Klaus W Lange; Christine Heim; Waclav Kolasiewicz; Oliver Tucha; Karl-Heinz Sontag
Journal:  J Neural Transm (Vienna)       Date:  2009-07-16       Impact factor: 3.575

8.  Sleep and circadian dysfunction in neurodegenerative disorders: insights from a mouse model of Huntington's disease.

Authors:  Dika Kuljis; Analyne M Schroeder; Takashi Kudo; Dawn H Loh; David L Willison; Christopher S Colwell
Journal:  Minerva Pneumol       Date:  2012-09

9.  Associations of sleep disturbance symptoms with health-related quality of life in Parkinson's disease.

Authors:  Alon Avidan; Ron D Hays; Natalie Diaz; Yvette Bordelon; Alexander W Thompson; Stefanie D Vassar; Barbara G Vickrey
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2013       Impact factor: 2.198

10.  Sleep Disorders as a Risk to Language Learning and Use.

Authors:  Karla K McGregor; Rebecca M Alper
Journal:  EBP Briefs       Date:  2015-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.